Literature DB >> 16757623

Combining multiplex reverse transcription-PCR and a diagnostic microarray to detect and differentiate enterovirus 71 and coxsackievirus A16.

Tsan-Chi Chen1, Guang-Wu Chen, Chao Agnes Hsiung, Jyh-Yuan Yang, Shin-Ru Shih, Yiu-Kay Lai, Jyh-Lyh Juang.   

Abstract

Cluster A enteroviruses, including enterovirus 71 (EV71) and coxsackievirus A16 (CA16), are known to cause hand-foot-and-mouth disease (HFMD). Despite the close genetic relationship between these two viruses, EV71 is generally known to be a more perpetuating pathogen involved in severe clinical manifestations and deaths. While the serotyping of enteroviruses is mostly done by conventional immunological methods, many clinical isolates remain unclassifiable due to the limited number of antibodies against enterovirus surface proteins. Array-based assays are able to detect several serotypes with high accuracy. We combined an enterovirus microarray with multiplex reverse transcription-PCR to try to develop a method of sensitively and accurately detecting and differentiating EV71 and CA16. In an effort to design serotype-specific probes for detection of the virus, we first did an elaborate bioinformatic analysis of the sequence database derived from different enterovirus serotypes. We then constructed a microarray using 60-mer degenerate oligonucleotide probes covalently bound to array slides. Using this enterovirus microarray to study 144 clinical specimens from patients infected with HFMD or suspected to have HFMD, we found that it had a diagnostic accuracy of 92.0% for EV71 and 95.8% for CA16. Diagnostic accuracy for other enteroviruses (non-EV71 or -CA16) was 92.0%. All specimens were analyzed in parallel by real-time PCR and subsequently confirmed by neutralization tests. This highly sensitive array-based assay may become a useful alternative in clinical diagnostics of EV71 and CA16.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757623      PMCID: PMC1489440          DOI: 10.1128/JCM.02393-05

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

1.  Development, technical performance, and clinical evaluation of a NucliSens basic kit application for detection of enterovirus RNA in cerebrospinal fluid.

Authors:  Christine C Ginocchio; Frank Zhang; Amisha Malhotra; Ryhana Manji; Peter Sillekens; Helma Foolen; Marlieke Overdyk; Margot Peeters
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

2.  Molecular detection and characterization of human enteroviruses directly from clinical samples using RT-PCR and DNA sequencing.

Authors:  Miren Iturriza-Gómara; Brian Megson; Jim Gray
Journal:  J Med Virol       Date:  2006-02       Impact factor: 2.327

3.  Detection by PCR of enteroviruses in cerebrospinal fluid during a summer outbreak of aseptic meningitis in Switzerland.

Authors:  M Gorgievski-Hrisoho; J D Schumacher; N Vilimonovic; D Germann; L Matter
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

4.  Immunohistochemical detection of infected neurons as a rapid diagnosis of enterovirus 71 encephalomyelitis.

Authors:  K T Wong; K B Chua; S K Lam
Journal:  Ann Neurol       Date:  1999-02       Impact factor: 10.422

5.  Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak.

Authors:  M J Cardosa; S Krishnan; P H Tio; D Perera; S C Wong
Journal:  Lancet       Date:  1999-09-18       Impact factor: 79.321

6.  Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications.

Authors:  S M Wang; C C Liu; H W Tseng; J R Wang; C C Huang; Y J Chen; Y J Yang; S J Lin; T F Yeh
Journal:  Clin Infect Dis       Date:  1999-07       Impact factor: 9.079

7.  Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998.

Authors:  B A Brown; M S Oberste; J P Alexander; M L Kennett; M A Pallansch
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998.

Authors:  S R Shih; M S Ho; K H Lin; S L Wu; Y T Chen; C N Wu; T Y Lin; L Y Chang; K C Tsao; H C Ning; P Y Chang; S M Jung; C Hsueh; K S Chang
Journal:  Virus Res       Date:  2000-07       Impact factor: 3.303

Review 9.  Highly parallel microbial diagnostics using oligonucleotide microarrays.

Authors:  Alexander Loy; Levente Bodrossy
Journal:  Clin Chim Acta       Date:  2005-08-26       Impact factor: 3.786

10.  Optimized SYBR green real-time PCR assay to quantify the absolute copy number of measles virus RNAs using gene specific primers.

Authors:  Sébastien Plumet; Denis Gerlier
Journal:  J Virol Methods       Date:  2005-09       Impact factor: 2.014

View more
  20 in total

1.  Molecular identification and analysis of nonserotypeable human enteroviruses.

Authors:  Fei Zhou; Fanrong Kong; Kenneth McPhie; Mala Ratnamohan; Gwendolyn L Gilbert; Dominic E Dwyer
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

2.  Simultaneously typing nine serotypes of enteroviruses associated with hand, foot, and mouth disease by a GeXP analyzer-based multiplex reverse transcription-PCR assay.

Authors:  Xiumei Hu; Yong Zhang; Xiaomian Zhou; Banglao Xu; Mengjie Yang; Miao Wang; Chen Zhang; Jin Li; Ruyin Bai; Wenbo Xu; Xuejun Ma
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

3.  External quality assessment for enterovirus 71 and coxsackievirus A16 detection by reverse transcription-PCR using armored RNA as a virus surrogate.

Authors:  Liqiong Song; Shipeng Sun; Bo Li; Yang Pan; Wenli Li; Kuo Zhang; Jinming Li
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

4.  Typing of enteroviruses by use of microwell oligonucleotide arrays.

Authors:  P Susi; L Hattara; M Waris; T Luoma-Aho; H Siitari; T Hyypiä; P Saviranta
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

Review 5.  Coxsackievirus A16: epidemiology, diagnosis, and vaccine.

Authors:  Qunying Mao; Yiping Wang; Xin Yao; Lianlian Bian; Xing Wu; Miao Xu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2013-11-14       Impact factor: 3.452

6.  Identification of 20 common human enterovirus serotypes by use of a reverse transcription-PCR-based reverse line blot hybridization assay.

Authors:  Fei Zhou; Fanrong Kong; Kenneth McPhie; Mala Ratnamohan; Linda Donovan; Frank Zeng; Gwendolyn L Gilbert; Dominic E Dwyer
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

7.  The association of recombination events in the founding and emergence of subgenogroup evolutionary lineages of human enterovirus 71.

Authors:  E C McWilliam Leitch; M Cabrerizo; J Cardosa; H Harvala; O E Ivanova; S Koike; A C M Kroes; A Lukashev; D Perera; M Roivainen; P Susi; G Trallero; D J Evans; P Simmonds
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

8.  Simultaneous detection and identification of enteric viruses by PCR-mass assay.

Authors:  Jingzi Piao; Jun Jiang; Bianli Xu; Xiaohong Wang; Yanfang Guan; Weili Wu; Licheng Liu; Yuan Zhang; Xueyong Huang; Pengzhi Wang; Jinyin Zhao; Xiaoping Kang; Hua Jiang; Yuanyin Cao; Yuling Zheng; Yongqiang Jiang; Yan Li; Yinhui Yang; Weijun Chen
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

9.  Development and evaluation of reverse transcription-loop-mediated isothermal amplification assay for rapid detection of enterovirus 71.

Authors:  Weifeng Shi; Kun Li; Yun Ji; Qingbo Jiang; Mei Shi; Zuhuang Mi
Journal:  BMC Infect Dis       Date:  2011-07-18       Impact factor: 3.090

10.  The association between enterovirus 71 infections and meteorological parameters in Taiwan.

Authors:  Hsiao-Ling Chang; Chia-Pin Chio; Huey-Jen Su; Chung-Min Liao; Chuan-Yao Lin; Wen-Yi Shau; Yun-Chan Chi; Ya-Ting Cheng; Yuan-Lin Chou; Chung-Yi Li; Kwo-Liang Chen; Kow-Tong Chen
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.